Balance Wealth, LLC
- SEC CIK
- 0002065247
- Latest filing
- Jul 21, 2026
The latest 13F from Balance Wealth, LLC covers Q2 2026 (filed Jul 21, 2026): 165 long positions worth $376.0M. The top 10 holdings make up 48.5% of the portfolio, and the largest is Invesco QQQ Trust Series I at 10.3%. Livermore has 6 filings on Form 13F from this institution, going back to Q1 2025.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 30
- Est. +$10.2M
- Added
- 74
- Est. +$24.8M
- Reduced
- 57
- Est. −$11.0M
- Sold out
- 14
- Est. −$7.84M
Top 5 holdings
Share of this quarter's portfolio value
- Invesco QQQ Trust Series I46090E10310.3%$38.8M
- Vanguard S&P 500 ETF9229083639.0%$33.8M
- J P Morgan Exchange Traded F46654Q7815.9%$22.0M
- Vanguard Malvern FDS9220207554.3%$16.0M
- State Street Health Care Select Sector SPDR ETF81369Y2093.8%$14.2M
Share of portfolio
Top 5 holdings and the other 160 positions, by share of portfolio value
- Invesco QQQ Trust Series I10.3%
- Vanguard S&P 500 ETF9.0%
- J P Morgan Exchange Traded F5.9%
- Vanguard Malvern FDS4.3%
- State Street Health Care Select Sector SPDR ETF3.8%
- Other 160 positions66.8%
Biggest buys
New and added positions, by estimated amount bought
- Vanguard S&P 500 ETF922908363+$6.03MAdded
- Invesco Nasdaq 100 ETF46138G649+$3.18MAdded
- Tidal Trust III45259A837+$2.16MNew
- Invesco QQQ Trust Series I46090E103+$2.02MAdded
- Vanguard Malvern FDS922020755+$1.33MAdded
Largest weight increases
New and added positions, by percentage points of the portfolio gained
- Vanguard S&P 500 ETF922908363+1.49 pp7.5% → 9.0%
- Invesco QQQ Trust Series I46090E103+1.37 pp9.0% → 10.3%
- Invesco Nasdaq 100 ETF46138G649+0.98 pp1.5% → 2.5%
- State Street Technology Select Sector SPDR ETF81369Y803+0.71 pp1.6% → 2.3%
- Tidal Trust III45259A837+0.57 pp0.0% → 0.6%
Biggest sells
Reduced and sold-out positions, by estimated amount sold
- Dimensional U.S. Core Equity 2 ETF25434V708−$4.39MReduced
- Global X FDS37960A370−$2.12MSold out
- Dimensional ETF Trust25434V831−$1.68MSold out
- Vanguard Intermediate-Term Corporate Bond ETF92206C870−$1.43MSold out
- iShares S&P Mid-Cap 400 Value ETF464287705−$1.33MReduced
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
- Dimensional U.S. Core Equity 2 ETF25434V708−1.20 pp1.3% → 0.1%
- Global X FDS37960A370−0.66 pp0.7% → 0.0%
- Dimensional ETF Trust25434V831−0.52 pp0.5% → 0.0%
- iShares S&P Mid-Cap 400 Value ETF464287705−0.51 pp3.4% → 2.9%
- Vanguard Intermediate-Term Corporate Bond ETF92206C870−0.44 pp0.4% → 0.0%
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $376.0M
- +$53.9M (+16.7%) vs. prior quarter
- Positions
- 165
- +16 vs. prior quarter
- Top 10 concentration
- 48.5%
- Top 10 as share of value
- Turnover
- 5.4%
- Q2 2026, one quarter
- Average holding period
- 5.0 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2025), so positions held before then are understated.
13F filings by quarter
6 quarters, going back to Q1 2025. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $404.8M (Q3 2025)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 21, 2026 | 165 | $376.0M | Invesco QQQ Trust Series IVanguard S&P 500 ETFJ P Morgan Exchange Traded F | vs. Q1 2026 | SEC |
| Q1 2026 | Apr 20, 2026 | 149 | $322.1M | Invesco QQQ Trust Series IVanguard S&P 500 ETFJ P Morgan Exchange Traded F | vs. Q4 2025 | SEC |
| Q4 2025 | Jan 21, 2026 | 143 | $311.6M | Invesco QQQ Trust Series IJ P Morgan Exchange Traded FState Street Health Care Select Sector SPDR ETF | vs. Q3 2025 | SEC |
| Q3 2025 | Oct 20, 2025 | 133 | $404.8M | Invesco QQQ Trust Series IiShares S&P Mid-Cap 400 Value ETFState Street Health Care Select Sector SPDR ETF | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 13, 2025 | 101 | $170.8M | J P Morgan Exchange Traded FSchwab U.S. Large-Cap ETFVanguard S&P 500 ETF | vs. Q1 2025 | SEC |
| Q1 2025 | Apr 23, 2025 | 110 | $153.9M | Schwab U.S. Large-Cap ETFJ P Morgan Exchange Traded FColumbia ETF Tr I | – | SEC |